Logo image of SQNS

SEQUANS COMMUNICATIONS-ADR (SQNS) Stock Fundamental Analysis

NYSE:SQNS - US8173233060 - ADR

0.898 USD
-0.01 (-1.43%)
Last: 8/29/2025, 8:04:00 PM
0.8806 USD
-0.02 (-1.94%)
After Hours: 8/29/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, SQNS scores 3 out of 10 in our fundamental rating. SQNS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While SQNS is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, SQNS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year SQNS was profitable.
SQNS had a negative operating cash flow in the past year.
In the past 5 years SQNS reported 4 times negative net income.
SQNS had a negative operating cash flow in each of the past 5 years.
SQNS Yearly Net Income VS EBIT VS OCF VS FCFSQNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

SQNS's Return On Assets of 61.05% is amongst the best of the industry. SQNS outperforms 99.11% of its industry peers.
SQNS has a better Return On Equity (129.98%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 61.05%
ROE 129.98%
ROIC N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SQNS Yearly ROA, ROE, ROICSQNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K 2K

1.3 Margins

Looking at the Profit Margin, with a value of 144.41%, SQNS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
SQNS has a better Gross Margin (70.17%) than 91.96% of its industry peers.
SQNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 144.41%
GM 70.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
SQNS Yearly Profit, Operating, Gross MarginsSQNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

More info and screens

2

2. Health

2.1 Basic Checks

SQNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SQNS has been increased compared to 1 year ago.
Compared to 5 years ago, SQNS has more shares outstanding
Compared to 1 year ago, SQNS has an improved debt to assets ratio.
SQNS Yearly Shares OutstandingSQNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
SQNS Yearly Total Debt VS Total AssetsSQNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.73, we must say that SQNS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.73, SQNS is not doing good in the industry: 65.18% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.11 indicates that SQNS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.11, SQNS is in line with its industry, outperforming 53.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACCN/A
WACC12.42%
SQNS Yearly LT Debt VS Equity VS FCFSQNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 1.83 indicates that SQNS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.83, SQNS is doing worse than 77.68% of the companies in the same industry.
SQNS has a Quick Ratio of 1.75. This is a normal value and indicates that SQNS is financially healthy and should not expect problems in meeting its short term obligations.
SQNS's Quick ratio of 1.75 is on the low side compared to the rest of the industry. SQNS is outperformed by 66.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.75
SQNS Yearly Current Assets VS Current LiabilitesSQNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

SQNS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 256.55%, which is quite impressive.
SQNS shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.05%.
The Revenue has been growing slightly by 3.60% on average over the past years.
EPS 1Y (TTM)256.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.22%
Revenue 1Y (TTM)32.05%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-15.84%

3.2 Future

Based on estimates for the next years, SQNS will show a very negative growth in Earnings Per Share. The EPS will decrease by -26.75% on average per year.
SQNS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.27% yearly.
EPS Next Y-148.4%
EPS Next 2Y-48.9%
EPS Next 3Y-26.75%
EPS Next 5YN/A
Revenue Next Year-5.51%
Revenue Next 2Y24.21%
Revenue Next 3Y20.27%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SQNS Yearly Revenue VS EstimatesSQNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SQNS Yearly EPS VS EstimatesSQNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.40, the valuation of SQNS can be described as very cheap.
100.00% of the companies in the same industry are more expensive than SQNS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of SQNS to the average of the S&P500 Index (27.13), we can say SQNS is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for SQNS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 0.4
Fwd PE N/A
SQNS Price Earnings VS Forward Price EarningsSQNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SQNS Per share dataSQNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

SQNS's earnings are expected to decrease with -26.75% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-48.9%
EPS Next 3Y-26.75%

More info and screens

0

5. Dividend

5.1 Amount

SQNS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEQUANS COMMUNICATIONS-ADR

NYSE:SQNS (8/29/2025, 8:04:00 PM)

After market: 0.8806 -0.02 (-1.94%)

0.898

-0.01 (-1.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners18.36%
Inst Owner Change289.08%
Ins Owners1.05%
Ins Owner ChangeN/A
Market Cap128.16M
Analysts82.86
Price Target5.61 (524.72%)
Short Float %13.01%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.83%
Min EPS beat(2)-1.2%
Max EPS beat(2)18.86%
EPS beat(4)2
Avg EPS beat(4)216.6%
Min EPS beat(4)-12.04%
Max EPS beat(4)860.78%
EPS beat(8)4
Avg EPS beat(8)101.43%
EPS beat(12)7
Avg EPS beat(12)80.87%
EPS beat(16)11
Avg EPS beat(16)71.46%
Revenue beat(2)1
Avg Revenue beat(2)-19.25%
Min Revenue beat(2)-48.17%
Max Revenue beat(2)9.67%
Revenue beat(4)3
Avg Revenue beat(4)17.48%
Min Revenue beat(4)-48.17%
Max Revenue beat(4)105.88%
Revenue beat(8)4
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)-1.82%
Revenue beat(16)5
Avg Revenue beat(16)-2.04%
PT rev (1m)-26.67%
PT rev (3m)-26.67%
EPS NQ rev (1m)35.71%
EPS NQ rev (3m)18.18%
EPS NY rev (1m)-13.83%
EPS NY rev (3m)-16.3%
Revenue NQ rev (1m)-20.78%
Revenue NQ rev (3m)-31.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.46%
Valuation
Industry RankSector Rank
PE 0.4
Fwd PE N/A
P/S 3.43
P/FCF N/A
P/OCF N/A
P/B 3.09
P/tB 4.52
EV/EBITDA N/A
EPS(TTM)2.27
EY252.78%
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.26
BVpS0.29
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 61.05%
ROE 129.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 144.41%
GM 70.17%
FCFM N/A
ROA(3y)2.44%
ROA(5y)-15.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.12%
GM growth 5Y13.43%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 76.17%
Cap/Sales 13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.75
Altman-Z 1.73
F-Score5
WACC12.42%
ROIC/WACCN/A
Cap/Depr(3y)234.19%
Cap/Depr(5y)223.55%
Cap/Sales(3y)59.67%
Cap/Sales(5y)52.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)256.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.22%
EPS Next Y-148.4%
EPS Next 2Y-48.9%
EPS Next 3Y-26.75%
EPS Next 5YN/A
Revenue 1Y (TTM)32.05%
Revenue growth 3Y-10.21%
Revenue growth 5Y3.6%
Sales Q2Q%-15.84%
Revenue Next Year-5.51%
Revenue Next 2Y24.21%
Revenue Next 3Y20.27%
Revenue Next 5YN/A
EBIT growth 1Y8.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y21.52%
EBIT Next 5YN/A
FCF growth 1Y-94.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6553.81%
OCF growth 3YN/A
OCF growth 5YN/A